Jacobo Mintzer

Author PubWeight™ 28.22‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol 2004 4.66
2 Relapse risk after discontinuation of risperidone in Alzheimer's disease. N Engl J Med 2012 4.22
3 Dementia with Lewy bodies. Lancet Neurol 2004 2.66
4 Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial. Curr Alzheimer Res 2008 1.84
5 Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. Am J Psychiatry 2003 1.40
6 Disease-modifying therapies in Alzheimer's disease. Alzheimers Dement 2008 1.39
7 Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial. Am J Geriatr Psychiatry 2005 1.27
8 The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials. Int J Geriatr Psychiatry 2007 1.24
9 Safety and benefits of distance-adjusted prefrontal transcranial magnetic stimulation in depressed patients 55-75 years of age: a pilot study. Depress Anxiety 2004 1.03
10 Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A 2012 0.95
11 Subgroup analysis of US and non-US patients in a global study of high-dose donepezil (23 mg) in moderate and severe Alzheimer's disease. Am J Alzheimers Dis Other Demen 2012 0.89
12 A markov model of the cost effectiveness of olanzapine treatment for agitation and psychosis in Alzheimer's disease. Clin Drug Investig 2008 0.85
13 The antipsychotic discontinuation in Alzheimer disease trial: clinical rationale and study design. Am J Geriatr Psychiatry 2012 0.84
14 Preliminary examination of progression of Alzheimer's disease in a rural Southern African American cohort. Arch Clin Neuropsychol 2007 0.84
15 Spinal cord injury: how can we improve the classification and quantification of its severity and prognosis? J Neurotrauma 2014 0.81
16 The many faces of psychosis in the elderly. Curr Opin Psychiatry 2007 0.79
17 Sertraline for the treatment of depression in Alzheimer disease: genetic influences. J Geriatr Psychiatry Neurol 2011 0.78
18 Elderly veterans with combat-related posttraumatic stress disorder in specialty care. J Nerv Ment Dis 2004 0.77
19 Depression in Alzheimer's disease: consequence or contributing factor? Expert Rev Neurother 2011 0.76
20 Commentary: "Ceramide and cholesterol: possible connections between normal aging of the brain and Alzheimer's disease. Just hypotheses or molecular pathways to be identified?" by Claudio Costantini, Rekha M.K. Kolasani, Luigi Puglielli. Alzheimers Dement 2005 0.75